Skip to main content
. 2021 May 10;12(13):3958–3966. doi: 10.7150/jca.53981

Figure 2.

Figure 2

Association between CDK5 expression and the clinicopathological features of patients with glioma in TCGA and GSE16011 cohorts. The clinical features include (A) age, (B) tumor grade, (C) histological type, (D) vital status, (E) KPS, (F) IDH1 mutation, (G) family history of cancer, and (H) tumor status. (I) The effects of CDK5 expression on the overall survival of patients are shown.